Published

Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Psychedelic Studies
Date: 2025-09-04
Source: OpenAlex
DOI: 10.1556/2054.2025.00461
PubMed: Unavailable

Authors

Alan K. Davis Meghan DellaCrosse Nathan D. Sepeda Adam W. Levin Mary P Cosimano Hillary Shaub Washington Taylor Peter M. Gooch Shoval Gilead Skylar J. Gaughan Stacey B. Armstrong Frederick S. Barrett

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Mechanism of Action Emotional Processing Randomized Controlled Trial Healthcare Workers Safety Adverse Events Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial2026-05-27 Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder2025-09-04

Related papers

Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.ClinicalTrials.gov · 2025-11-19 Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-07-21